Open access

Diets for patients undergoing haematopoietic stem cell transplant—a review

Publication: LymphoSign Journal
27 October 2020

Abstract

At present there is no known consensus or standard of practice when recommending diet modifications for patients undergoing haematopoietic stem cell transplant (HSCT). There is large variation between centres in terms of which patients are required to follow a restricted diet, what foods are or are not permitted, and how long patients should follow a modified or restricted diet. Some centres continue to recommend outdated highly restrictive “neutropenic” or “low bacteria” (ND/LBD) diets despite a lack of evidence indicating benefit. Many centres are now moving towards more liberalized diets based on a “food safety” approach which follows guidelines from food and health agencies such as the FDA, CDC, and Health Canada, as well as research that shows that these diets are equally safe and potentially more beneficial than ND/LBD in terms of acceptance, satisfaction, and adherence. This article reviews and discusses the current body of literature relating to diet post-HSCT.
Statement of novelty: An up-to-date review of diets recommended post-HSCT and a rationale for moving towards a food-safety based approach over neutropenic or low bacteria diets, which continue to be widely followed.

Introduction

Diet recommendations for patients undergoing haematopoietic stem cell transplant (HSCT) have evolved over the years, but no standard of practice currently exists and there is broad variability between centres in terms of nutrition-related practices and guidelines on all levels—local, national, and international (Lipkin et al. 2005; Fox and Friefeld 2012; Vicenski et al. 2012; Lassiter and Schneider 2015; Baumgartner et al. 2017a, 2017b; Moody et al. 2018; Wolfe et al. 2018; Barnett 2019; Moody 2019; Taggart et al. 2019). Despite a lack of evidence linking intake of specific foods to incidence of infection, post-HSCT complications such as Graft vs. Host Disease (GvHD), overall survival rates, or indeed conferral of a protective effect in any way secondary to avoidance of particular foods, many centres continue to recommend restrictive diets for their HSCT patients. These recommendations are based largely on historical practice related to theoretical risk, adherence to outdated policies, and a lack of consensus across centres or in the literature (Tramsen et al. 2016; Baumgartner et al. 2017b, 2018; Barnett 2019; Moody 2019; Taggart et al. 2019).

History and background of restrictive diets in HSCT

Restrictive diets for HSCT patients appeared in the 1960s, in combination with other practices thought to be protective against infection. These practices included patient isolation, sterilization of linens, clothing, and equipment, and prophylactic antibiotic use to “decontaminate” and “cleanse” the gut in addition to a heavily restricted diet, meant to be followed for at least 6 months after allogeneic HSCT (Fox and Friefeld 2012; Lassiter and Schneider 2015; Moody et al. 2018; Wolfe et al. 2018; Moody 2019; Taggart et al. 2019). The diet has been called many things over the years, primarily the “neutropenic diet” (ND), used for both oncology and HSCT patients, and more recently the “low bacteria diet” (LBD). The rationale for the ND/LBD diet came from a belief that bacteria commonly found in food and introduced into a gut weakened by harsh conditioning regimens and post-HSCT side effects, such as mucositis, would increase the risk and incidence of bloodstream infections as a result of translocation from the gut into the bloodstream (Fox and Friefeld 2012; Lassiter and Schneider 2015; Wolfe et al. 2018; Taggart et al. 2019). Particular emphasis was placed on bacteria commonly found on raw fruit and vegetables, including enterobacter and pseudomonas bacteria, as these were considered to be particularly dangerous pathogens in a significantly immunocompromised patient (Wolfe et al. 2018). As a result, fresh fruits and vegetables in addition to other foods considered high risk (such as raw nuts, cream (fresh or shelf stable) and custards, yoghurt with live cultures, some pickled foods, undercooked meat and eggs, and unpasteurized dairy) were restricted. The restrictions imposed by the ND/LBD led to diets high in processed foods, and limited in sources of fibre and vitamin C due to the complete removal of fresh fruits and vegetables (Wolfe et al. 2018; Taggart et al. 2019), potentially predisposing post-HSCT patients to other diet-related complications including vitamin and mineral deficiencies, hypertension due to increased sodium intake (from processed foods), and decreased overall bowel health due to minimal fibre intake (Taggart et al. 2019). Despite literature showing that incidence of food-borne illness post-HSCT is extremely rare (an 0.3% incidence over an 11 year period, as shown by Boyle et al. (2014)), and a better understanding of the function of the gut, variations of the ND/LBD persist, and are still widely recommended across HSCT centres, even as other total-protective-environment practices such as sterilization of equipment and linen have been abandoned (Lipkin et al. 2005; Fox and Friefeld 2012; Baumgartner et al. 2017b; Wolfe et al. 2018).

Current practice

With an increasing body of evidence supporting use of a more liberal diet, many North American centres are moving towards a less restricted, food-safety based (FSB) approach, backed further by guidelines from food and health agencies including the CDC, USDA, FDA, and Health Canada (Tramsen et al. 2016; Baumgartner et al. 2017a; Barnett 2019). Most paediatric centres in Canada now follow the FSB approach, which patients and families find far more palatable than the restrictive diets of the past, and as a result, much easier to adhere to (Neumann et al. 2016; Tramsen et al. 2016; Baumgartner et al. 2018; Barnett 2019). At present, SickKids Hospital in Toronto, Ontario, follows the FSB approach, recommending a significantly liberalized diet compared to past practice (Stuhler 2017, 2019). Out of familiarity, the diet is still called the “low bacteria diet” (Table 1, 2) but is entirely food-safety based, and adapted from Health Canada’s diet recommendations for immunocompromised individuals (Health Canada 2012, 2015). The food-safety approach followed by SickKids and many other centres focuses on safe food handling and preparation (Table 3), and avoidance of foods that are known to have the potential to cause food-borne illness, including undercooked eggs, meat, poultry, and fish, and unpasteurized dairy products. Fresh fruits and vegetables, heavily restricted in the past, are allowed, enhancing the overall nutritional composition of the diet with the reintroduction of vitamins, minerals, and fibre. Yoghurt and kefir are allowed, as are pickled and some fermented products such as kimchi and sauerkraut. Food from restaurants, if safely prepared, is permitted. Municipal tap water is allowed, and sterile or boiled water not recommended except in the case of untested well water supply or for preparation of infant or therapeutic enteral formulas (Health Canada 2015; Stuhler 2017, 2019). Palatability and access to food (particularly for families far from home and without good kitchen facilities) is increased with the FSB approach. There may also be institutional cost-saving advantages to adoption of the FSB diet, as less work, staff, and special products are required at the hospital-level to support the diet (Moody et al. 2018). Despite this trend, enormous amounts of variability still exists in terms of centre-to-centre practices around diet recommendations. In a survey of 17 Swiss centres performing HSCTs, Baumgartner et al. (2017b) found no consensus in terms of existence of an HSCT-specific diet, particularly for autologous-HSCT patients (as some centres did not require any type of special diet for this group), recommended length of time a diet should be followed if it was in place, and which foods were allowed while following the diet. While there were similarities noted in terms of food preparation and recommended avoidance of undercooked meat/fish/eggs and unpasteurized dairy, some centres continued to advise against eating raw fruits and vegetables while others allowed it. Vicenski et al. (2012) describe similar inconsistencies across 17 centres in Brazil, and other studies report the same variation in practice in other parts of the world (Lipkin et al. 2005; Fox and Friefeld 2012; Baumgartner et al. 2017a; Wolfe et al. 2018; Barnett 2019; Moody 2019). A body of literature is emerging showing minimal benefit of the ND/LBD approach in comparison to a FSB diet, which may help standardize approaches in the future.
Table 1:
Table 1: Post-HSCT diet general guidelines. Adapted from “Foods to Avoid on a Low Bacteria Diet” (Stuhler 2019).
Table 2:
Table 2: Post-HSCT diet foods to avoid. Adapted from “Foods to Avoid on a Low Bacteria Diet” (Stuhler 2019).
a
Either in the microwave, a pan, or the oven. Cold cuts may be heated until steaming, and then cooled in the fridge before serving (they do not need to be served hot).
Table 3:
Table 3: General guidelines for safe food preparation and handling practices after HSCT. Adapted from “Safe Food Preparation and Handling after a Blood and Marrow Transplant” (Stuhler 2017).

Current body of evidence

In the last decade, increased interest in understanding the importance of nutrition in HSCT has emerged, with many groups acknowledging how little is known about the way pathogens that are found on food (such as those bacteria commonly found on the surfaces of fresh fruits and vegetables) interact with the gut once ingested, and whether or not they are likely to cause harm in the post-HSCT gut (Fox and Friefeld 2012; Boyle et al. 2014; Lassiter and Schneider 2015). Multiple groups have been unable to demonstrate a causal link between food and infection or proof that use of a ND/LBD leads to decreased incidence of infection (Fox and Friefeld 2012; Tramsen et al. 2016; Baumgartner et al. 2017a; Moody et al. 2018; Barnett 2019; Moody 2019; Taggart et al. 2019), leading to a growing group of researchers interested in finding out more about this subject.
In a 2018 review of the literature, Baumgartner et al. (2018) found no positive influence on overall rates of infection, incidence of bacteremia or fungemia, or mortality in patients receiving a more restricted diet, and reported that some studies showed an increased risk of infection within the ND/LBD group. Tramsen et al. (2016) saw no effect on fever, bacteremia, incidence of pneumonia and gastrointestinal infections with use of a restricted diet and state that based on their findings the ND/LBD approach cannot be considered more effective or indeed necessary. Moody (2019) report no conferred protective effect for those receiving a restricted diet in terms of infection rates, and Neumann et al. (2016) saw no increases in norovirus or central-line associated bloodstream infections (CLABSI) in the FSB group. Taggart et al. (2019) completed the first randomized control trial in paediatric HSCT comparing infections (bloodstream and gastrointestinal), incidence of GvHD, and overall survival using a before- and after-study design with a ND/LBD and FSB diet. Looking at the first 100 days post-HSCT, they found no difference in incidence of bloodstream infections, no increased incidence in norovirus infections, no noted increase in incidence of gut-GvHD, or differences in overall survival rates between groups (Taggart et al. 2019). Based on their findings, they recommend that all centres follow a FSB-approach. This recommendation follows those by Baumgartner, Tramsen, Moody, and other groups who believe in the safety of the FSB method (Fox and Friefeld 2012; Trifilio et al. 2012; Boyle et al. 2014; Tramsen et al. 2016; Baumgartner et al. 2018; Moody et al. 2018; Wolfe et al. 2018; Barnett 2019; Moody 2019).
Although most studies have found no difference in infections between groups following ND/LBD and FSB diets, a few groups have seen increased complications in the ND/LBD groups, including Baumgartner et al. (2018) as described above, and Trifilio et al. (2012), who noted increased rates of infections and urinary tract infections in the group receiving a restricted diet. Baumgartner et al. (2018) also reported higher heart rates in the ND group, which they could not explain. These and other teams hypothesize that many bacteria commonly found on food are a part of the normal gut flora and do not act in a harmful way once colonized in the gut (Fox and Friefeld 2012; Trifilio et al. 2012; Boyle et al. 2014; Lassiter and Schneider 2015; Wolfe et al. 2018; Taggart et al. 2019). Instead, they may confer a protective effect by maintaining the patient’s normal gut flora. Any shifts in nutritional intake (either imposed or natural as a result of HSCT-related side effects) or addition of medications that impact the gut (such as antibiotics) may impact the makeup and function of the gut flora and microbiome, potentially leading to increased risk of infection (Fox and Friefeld 2012; Wolfe et al. 2018; Taggart et al. 2019). This has not yet been proven, but is one of the main arguments for a more liberalized diet given emerging evidence of the importance of the microbiome for HSCT patients (Wolfe et al. 2018).
Some groups have described the psychological benefits of a more liberal, FSB-based diet, including Lassiter and Schneider (2015) who found patients following a more liberalized FSB-based diet were better nourished overall and reported increased quality of life scores. Increased satisfaction when following a FSB diet was noted in other studies as well, as was increased adherence to the diet (Fox and Friefeld 2012; Neumann et al. 2016; Baumgartner et al. 2018; Wolfe et al. 2018; Barnett 2019).
Based on these findings, there appears to be no benefit in continuing to recommend a heavily restricted ND/LBD-type of diet for HSCT patients, as these diets may lead to suboptimal nutrition status, decreased perceived quality of life, and perhaps even increased infection and potential harm (Trifilio et al. 2012; Boyle et al. 2014; Baumgartner et al. 2017a, 2018; Moody et al. 2018; Barnett 2019).

Counselling focus

Regardless of the diet a centre chooses to follow, focus should be placed on ensuring that patients receive clear, concise, and practical resources, and if applicable, education. All staff members, regardless of role, should be well versed in the diet, so that information provided to families is consistent. When limited resources make in-person diet teaching challenging, patient education materials must be available that are easy to read, understand, and access. Ideally patient education materials should be available in multiple languages. At present, the guidelines used at SickKids are available online for open use, and can be accessed in English, French, Arabic, and simplified Chinese. Further translation into other languages commonly seen in the SickKids HSCT patient population including Urdu, Bengali, Hindi and Portuguese will hopefully happen in the near future.

Conclusion

There is still so little known about the role nutrition plays in those undergoing HSCT. However, based on the findings of the groups above, choosing a food safety based diet for HSCT patients is not only safe, but superior given the positive impact the diet can have on quality of life and overall nutritional status. Discarding the old neutropenic or low bacteria diets in favour of the FSB diet is a safe and responsible choice for the future. Ensuring that all staff involved in provision of care for HSCT patients are educated about the diet, and resources available to patients and families are easily accessible and up-to-date is key.

REFERENCES

Barnett, J. February 2019. To neutropenic diet or not to neutropenic diet? Support Line, 16–20.
Baumgartner A., Bargetzi A., Zueger N., Bargetzi M., Medinger M., Bounoure L., Gomes F., Stanga Z., Mueller P., and Shuetz P. 2017a. Revisiting nutritional support for allogeneic haematopoietic stem cell transplantation—A systematic review. Bone Marrow Transplant. 52: 506–513.
Baumgartner A., Bargetzi M., Bargetzi A., Zueger N., Medinger M., Passweg J., Schanz U., Samaras P., Chalandon Y., Picard C., Limota A., Wannesson L., Pabst T., Duchosal M.A., Hess U., Stanga Z., Mueller B., and Schuetz P. 2017b. Nutritional support practices in haematopoietic stem cell transplantation centres: A nationwide comparison. Nutrition, 35: 43–50.
Baumgartner A., Hoskin K., and Schuetz P. 2018. Optimization of nutrition during allogeneic hematologic stem cell transplantation. Curr. Opin. Clin. Nutr. Metab. Care, 21(3): 152–158.
Boyle N.M., Podczervinski S., Jordan K., Stednick Z., Butler-Wu S., McMillen K., and Pergam S.A. 2014. Bacterial foodborne infections after hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 20: 1856–1861.
Fox N. and Friefeld A. 2012. The neutropenic diet reviewed: Moving toward a safe food handling approach. Oncology, 26(6): 572–575.
Health Canada. 2015. Safe food handling for immunocompromised individuals [online]. Available from http://nada.ca/wp-content/uploads/2017/03/immune-immunitaire-eng.pdf.
Lassiter M. and Schneider S.M. 2015. A pilot study comparing the neutropenic diet to a non-neutropenic diet in the allogeneic haematopoietic stem cell transplantation population. Clin. J. Oncol. Nurs. 19(3): 273–278.
Lipkin A.C., Lenssen P., and Dickson B.J. 2005. Nutrition issues in hematopoietic stem cell transplantation: State of the art. Nutr. Clin. Pract. 20(4): 423–439.
Moody K.M. 2019. Neutropenic dietary restrictions for haematopoietic stem cell patients: Time for a change. Biol. Blood Marrow Transplant. 25: e223–e225.
Moody K.M., Baker R.A., Santizo R.O., Olmez I., Spies J.M., Buthmann A., Granowetter L., Dulman R.Y., Ayyanar K., Gill J.B., and Carroll A.E. 2018. A randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patients. Pediatr. Blood Cancer, 65: e26711.
Neumann N., Taggart C., Lane A., Dandoy M., and Grimley M. 2016. Food safety guidelines vs. traditional low bacteria diet: Is there a difference in infection risk, quality of life and days of TPN following pediatric hematopoietic stem cell transplantation (HSCT)? J. Acad. Nutr. Diet. 116(9): A81.
Stuhler, R. 2017. Safe food handling and preparation after a blood and marrow transplant [online]. Available from https://www.aboutkidshealth.ca/Article?contentid=1547&language=English.
Taggart C., Neumann N., Badia Alonso P., Lane A., Pate A., Stegman A., Stendahl A., Davies S.M., Dandoy C.E., and Grimley M. 2019. Comparing a neutropenic diet to a food safety-based diet in paediatric patients undergoing haematopoietic stem cell transplant. Biol. Blood Marrow Transplant. 25: 1382–1386.
Tramsen L., Salzmann-Manrique E., Bochennek K., Klingebiel T., Reinhardt D., Creutzig U., Sung L., and Lehrnbecher T. 2016. Lack of effectiveness of neutropenic diet and social restrictions as anti-infective measures in children with acute myeloid leukemia: An analysis of the AML-BFM 2004 trial. J. Clin. Oncol. 34(23): 2776–2783.
Trifilio S., Helenowski I., Giel M., Gobel B., Pi J., Greenberg D., and Mehta J. 2012. Questioning the role of a neutropenic diet following hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 18: 1385–1390.
Vicenski P.P., Alberti P., and do Amaral D.J. 2012. Dietary recommendations for immunosuppressed patients of 17 hematopoietic stem cell transplantation centers in Brazil. Rev. Bras. Hematol. Hemoter. 34(2): 86–93.
Wolfe H.R., Sadeghi N., Agrawal D., Johnson D.H., and Gupta A. 2018. Things we do for no reason: Neutropenic diet. J. Hosp. Med. 13(8): 573–576.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 7Number 4December 2020
Pages: 115 - 121

History

Received: 9 September 2020
Accepted: 8 October 2020
Accepted manuscript online: 27 October 2020

Authors

Affiliations

Rivanna Stuhler [email protected]
Hospital for Sick Children (SickKids), Toronto, ON

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Get Access

Login options

Check if you access through your login credentials or your institution to get full access on this article.

Subscribe

Click on the button below to subscribe to LymphoSign Journal

Purchase options

Purchase this article to get full access to it.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media